Allergens
V01
Molecular characterization of the allergenic non-specific Lipid Transfer protein Pla
a 3 from plane tree pollen
A.Wangorsch1, H. Larsson2, M. Messmer1, M. Garcia Moral3, I. Lauer1, S. Wolfheimer1,
J. Bartra3, S. Vieths1, J. Lidholm2, S. Scheurer1
1
Paul-Ehrlich-Institut, Langen, Deutschland;
2
Thermo Fisher Scientific, Uppsala, Schweden;
3
Pneumology Department, Allergy Unit, Hospital Clinic, Barcelona, Spanien
Lipid transfer proteins (LTP) are considered to provoke plane pollen allergy, which
frequently is associated with peach allergy. Aim of the study was the cDNA cloning
of plane LTP Pla a 3, and to apply recombinant (r) Pla a 3 for molecular diagnosis
in comparison to its natural (n) counterpart and peach LTP Pru p 3.
Two isoforms of Pla a 3 were identified, at which Pla a 3 (AM286249) was over-expressed
and purified. nPla a 3 was purified from plane pollen extract and verified by MS.
Secondary structure of the proteins were analyzed by CD spectroscopy. Specific IgE
levels to plane pollen, rPla a 3, nPla a 3 and rPru p 3 were measured by ImmunoCAPTM
in serum of (I) plane pollen allergic patients without peach allergy (n=10), (II)
peach allergics without plane pollen allergy (n=15) and (III) plane and peach allergics
(n=15). Allergenic potency of rPla a 3, nPla a 3 and rPru p 3 was investigated by
in vitro mediator release assays. IgE cross-reactivity was assessed by ELISA.
Expression of both Pla a 3 isoforms was confirmed in plane tree pollen. rPla a 3 and
rPru p 3 showed reasonable purity and structural integrity. Recombinant and nPla a
3 displayed same IgE binding capacities. 24/25 plane pollen allergic patients were
sensitized to plane extract. Frequency of sensitization to Pla a 3 was 10 % in plane
pollen allergics and 53 % in peach allergic patients. In plane pollen and peach allergics
87 % of the patients were co-sensitized to rPla a 3 and rPru p 3. All proteins displayed
allergenic potency and showed strong IgE cross-reactivity, at which Pru p 3 displayed
highest IgE-binding.
rPla a 3 is a suitable tool for component-resolved allergy diagnosis. Pla a 3 does
not act as primary sensitizer for plane pollen allergy and does not serve as diagnostic
marker in plane pollen allergics without peach allergy. In patients with allergy to
plane and peach, IgE reactivity to Pla a 3 is likely due to primary sensitization
to Pru p 3 and subsequent cross-reactivity to plane LTP.
V02
Minor Allergens in Birch Allergen Products – Is Standardization Possible?
J. Zimmer, S. Döring, D. Strecker, F. Führer, J. Trösemeier, S. Vieths, S. Kaul
Paul-Ehrlich-Institut, Langen, Deutschland
Birch (Betula) pollen is a major cause of allergy in northern and central Europe.
The allergenic potency of products for diagnosis and therapy of birch pollen allergy
is adjusted nearly exclusively to the major birch pollen allergen Bet v 1. However,
many patients have also specific IgE-antibodies against minor birch pollen allergens
like Bet v 4, Bet v 6 and Bet v 7. The content of these minor allergens is currently
not controlled in birch allergen products and their clinical relevance remains undetermined.
We developed and validated ELISAs for quantification of Bet v 4, Bet v 6, and Bet
v 7 and determined these allergens in birch pollen allergen products from different
manufacturers (prick test solutions [PTS], products for sublingual [SLIT] and subcutaneous
immunotherapy [SCIT]). The results were also analysed in relation to allergenic activity,
Bet v 1 and total protein content as laid down in the Monograph on Allergen Products
in the European Pharmacopoeia.
All assessed products complied with their respective specifications for these parameters.
Moreover, we could detect all three minor allergens in each of the assessed products.
However, their concentration was highly variable when comparing different products
and manufacturers and even in several batches of the same product (PTS, SLIT and SCIT
products alike). While allergenic activity, Bet v 1 and total protein content were
clearly interdependent, none of the minor allergens showed a similarly strong correlation
with these factors. Without adaptations to the current manufacturing processes, it
therefore seems unfeasible to standardize birch allergen products also to minor allergens.
Nevertheless, a future combination of data on minor allergen content in different
birch allergen products on the one hand and clinical observations in birch pollen
allergic subjects on the other hand could clarify the clinical relevance of minor
allergens.
V03
Antigens 5 of different hymenoptera species are highly cross-reactive and do not allow
the clear identification of the culprit venom
M. Schiener1, M. McIntyre2, U. Darsow2, L. Schwarze3, C. Schmidt-Weber1, E. Spillner4,
M. Ollert5, S. Blank1
1
Center of Allergy & Environment (ZAUM), Institute of Allergy Research, Member of the
German Center for Lung Research (DZL),Technical University and Helmholtz Center Munich,
Germany;
2
Department of Dermatology and Allergy Biederstein, Technische Universität München,
Germany;
3
Institute of Biochemistry and Molecular Biology, University of Hamburg, Germany;
4
Immunological Engineering, Department of Engineering, Aarhus University, Denmark;
5
Department of Infection and Immunity, Centre de Recherche Public de la Santé (CRP-Santé),
Luxembourg, Luxembourg
Background: Allergies due to the venoms of hymenoptera can cause severe systemic reactions.
In spite of the progress of component-resolution in the last years, diagnosis as well
as therapy of venom allergy is still challenging. Amongst others this is due to extensive
cross-reactivity between different venoms. In this study the antigens 5 of 7 hymenoptera
species were recombinantly produced, characterized in detail and their cross-reactivity
analyzed.
Methods: The antigens 5 Ves v 5, Vesp c 5, Pol d 5, Pol a 5, Dol m 5, Sol i 3 and
the potentially hypoallergenic Poly s 5 were recombinantly produced in insect cells.
The resulting purified proteins were characterized by immunoblotting und structural
models were generated. Moreover, sera of venom allergic patients were assessed for
IgE cross-reactivity.
Results: All antigens 5 were successfully produced in Sf9 insect cells. As expected
from sequence alignments structural models reveal identical folding, although surface
charges differ between the different molecules. Immunoblot analyses showed the presence
of N-linked glycan structures only for Sol i 3. However, due to the use of Sf9 cells
as expression host all antigens 5 were devoid of carbohydrate-based cross-reactivity.
The analysis of sera from antigen 5-reactive patients revealed extensive cross-reactivity
of all antigens 5, independent of glycosylation. Some sera showed distinct reactivity
profiles with the diverse antigens 5 and others reacted with all of them, indicating
the presence of shared as well as of individual IgE epitopes.
Conclusion: The comparative analysis of antigens 5 from 7 different hymenoptera species
revealed extensive cross-reactivity between all allergens on protein level. This implicates
that antigens 5 are inappropriate marker allergens for the diagnostic discrimination
between antigen 5-containing venoms. Moreover, detailed analyses on a molecular level
can contribute to elucidate the clinical impact in the observed cross-reactivity.
V04
ImmunoCAP cellulose displays cross-reactive carbohydrate epitopes and can cause false-positive
test results in patients with anti-CCD IgE antibodies
W. Hemmer
Floridsdorf Allergy Centre, Vienna, Austria
Rationale: CCDs in plant and insect venom extracts may cause false-positive in vitro
test results. We noticed that some CCD-positive sera show multiple positive ImmunoCAP
results even with CCD-free recombinant allergens.
Methods: IgE-binding to recombinant allergens and to allergen-free blank ImmunoCAPs
(BIC) was compared in CCD-positive sera before and after CCD inhibition.
Results: 35/52 (67 %) CCD-positive sera (bromelain 1.01–59.6 kU/l) reacted with BIC
≥0.35 kU/l (0.35–4.22 kU/l). IgE-binding to BIC correlated with binding to bromelain
(r=0.80) and was completely abolished by a CCD inhibitor. Binding to another five
lots of BIC was lower but correlated strongly with the first lot (r≥0.94). Of 10 CCD-reactive
sera (14.0–52.5 kU/l) tested on recombinant Phl p12, Fel d 1, Ara h 2, and Pru p 3,
8 were positive to all components (0.36–1.6 kU/l), 2/10 showed borderline results.
Binding to components correlated with binding to bromelain (r=0.61) and BIC (r=0.97)
and was completely blocked by CCDs. MS confirmed the presence of MMXF glycans in unprocessed
and processed cellulose.
Conclusions: The ImmunoCAP cellulose allergen carrier contains varying traces of CCDs
and can cause false-positive results to non-glycosylated allergens in patients with
high levels of anti-CCD IgE antibodies.
V05
Anti- and pro-inflammatory properties of Aspergillus fumigatus cell wall chitin
K. L. Becker1, V. Aimanianda2, X. Wang1, M. Gresnigt1, M. Jaeger1, T. Crisan1, A.
Ammerdorffer1, M. Oosting1, R. Gazendam3, L. Joosten1, M. Netea1, J. Latge2, F. van
de Veerdonk1
1
Radboudumc, Nijmegen, The Netherlands;
2
Institut Pasteur, Paris, France;
3
Sanquin Research and Landsteiner Laboratory, Amsterdam, The Netherlands
Chitin is an important cell wall component of Aspergillus fumigatus spores of which
hundreds are inhaled on a daily basis. Chitin is not a structure of human cells, but
humans have chitinases. Elevated chitinase levels in serum were found in asthma patients,
and chitin induces accumulation of immune cells associated with allergy. Previous
studies have shown that chitin has both anti- and pro-inflammatory properties; however
the exact mechanisms determining the inflammatory signature of chitin are poorly understood.
We investigated the stimulation signatures induced in human peripheral blood mononuclear
cells (PBMCs) by chitin in the presence or absence of human serum. Cytokines were
measured in the cell culture supernatant by ELISA. Chitin showed an anti-inflammatory
signature characterized by the production of IL-1Ra, which was dependent on opsonisation
by immunoglobulins, internalization, and PI3K/Akt activation. In contrast, proinflammatory
cytokines and IL-10 were not induced by chitin. Depletion of immunoglobulins and blocking
the phagocytosis with cytochalasin D resulted in decreased IL-1Ra induction, while
IL-1β production was increased. Heat inactivation of Ig depleted serum reduced IL-1β
production suggesting a complement dependent pathway. Co-stimulation of chitin with
non-fungal pattern recognition ligands (LPS, P3Cys or MDP) had synergistic effects
on the induction of pro-inflammatory cytokines.
We conclude that chitin can have pro- and anti-inflammatory properties, depending
on the presence of PAMPs and immunoglobulins during the stimulation. We hypothesize
that human chitinases degrade chitin into small oligosaccharides to prevent the host
from exaggerated pro-inflammatory responses to inhaled A. fumigatus conidia.
V06
Glutaraldehyde-modified birch pollen allergoid reveals high stability to endolysosomal
degradation by dendritic cells
M. M. Rauber1, D. Werner2, B. Jahn-Schmid2, C. Möbs1, W. Pfützner1, B. Bohle2
1
Klinische und Experimentelle Allergologie, Klinik für Dermatologie und Allergologie,
Marburg, Deutschland;
2
Abteilung für Allergieforschung, Institut für Pathophysiologie und Allergieforschung,
Wien, Österreich
Background: Allergen-specific immunotherapy (AIT) is the only causative treatment
for immediate type allergies. During AIT side effects like anaphylactic reactions
can occur. To improve the safety of AIT, chemically-modified allergen extracts, so
called allergoids, have been introduced. Although allergoids are used in clinical
practice routinely, immunological alterations are poorly described. Still, there are
first evidences that allergoid-induced tolerance might be mediated by different immunological
mechanisms than AIT with native allergen extracts.
Aim: We sought to determine the stimulatory capacity of allergoids in allergen-specific
T cell lines (TCL) and to assess their endolysosomal digestion by antigen presenting
cells.
Methods: Birch pollen (BP) allergoid was synthesized by glutaraldehyde (GA) modification
and characterized in terms of molecular composition. In addition, binding of human
BP-specific IgE and a Bet v 1-specific monoclonal antibody was investigated. BP-specific
TCL were generated from PBMC of BP-allergic patients and stimulated with GA-modified
and non-modified BP extract as well as Bet v 1. Endolysosomal degradation of allergoid
by antigen-presenting cells was analyzed in vitro using endolysosomal proteases isolated
from the murine dendritic cell line JAWS II.
Results: GA-modification of BP extract led to a diverse high-molecular weight allergen
polymer with strongly reduced antibody binding. Proliferation assays with BP-specific
TCL revealed decreased stimulatory capacity of the allergoid in comparison to native
BP extract and Bet v 1. Of note, the allergoid was still stable after 24h of degradation
with endolysosomal extracts while the majority of Bet v 1 was degraded.
Conclusion: Allergoids show reduced T cell stimulatory capacity compared to native
allergen extract. While others have demonstrated retarded internalization of allergoids
by dendritic cells, our data provide evidence that in addition their endolysosomal
processing is delayed.
Immunology
V07
Dendritic cells are activated upon inhibiton of tankyrases
M. Bros, R. Käfer, E. Montermann, I. Tubbe, A. Reske-Kunz
Hautklinik, Universitätsmedizin Mainz, Deutschland
Constitutive activation of the canonical wingless (WNT) pathway that induces high-level
expression of ß-catenin target genes is a hallmark of many tumors. Several WNT inhibitors
developed for cancer therapy are under clinical investigation. Immune cells are regulated
in terms of differentiation and activation by the WNT pathway as well. Here we asked
for potential effects of WNT inhibitors on the acitvity of dendritic cells (DCs) as
the major regulators of peripheral tolerance and immunity. For this, we employed mouse
bone marrow-derived DCs (BMDCs).
Treatment of unstimulated BMDCs with inhibitors that targeted ß-catenin resulted in
moderate upregulation of MHCII and costimulators in a dose-dependent manner. However,
their T cell stimulatory capacity remained unaffected. In contrast, the inhibitor
XAV-939, engineered to prevent cellular accumulation of ß-catenin by tankyrase inhibiton,
yielded pronounced DC activation. Application of XAV-939 exerted no effect on BMDCs
stimulated with LPS. Ovalbumin-loaded DCs treated with XAV-939 promoted enhanced proliferation
of antigen-specific CD8+ (OT-I) and CD4+ (OT-II) T cells, and favoured production
of Th1/Th17-associated cytokines. Structurally different tankyrase inhibitors yielded
similar results as obtained when using XAV-939. These results suggest that tankyrases
may serve to limit activation of DCs under basal conditions.
V08
KSRP constitutes an important posttranscriptional negative regulator of cytokine and
chemokine production by activated dendritic cells
J. Schupp1, E. Montermann1, F. Bollmann2, A. Pautz2, H. Kleinert2, A. Reske-Kunz1,
M. Bros1
1
Hautklinik, Universitätsmedizin Mainz, Deutschland;
2
Institut für Pharmakologie, Universitätsmedizin Mainz, Deutschland
Posttranscriptional gene regulation has been recognized as an important checkpoint
of immune cell differentiation and activation. So far, the focus of research has been
on miRNA species that inhibit the stability and/or translational efficiency of their
cognate mRNA targets. However, RNA-binding proteins constitute important posttranscriptional
regulators of gene expression as well. Many RNA-binding proteins bind AU-rich mRNA
sequence stretches, and govern mRNA stability/translation.
Here we asked for the role of the RNA-binding protein KSRP (KH-type splicing regulatory
protein) known to promote mRNA decay in dendritic cells (DCs). Mouse bone-marrow derived
DCs (BMDCs) derived from wild type (WT) and KSRP-/- progenitor cells displayed comparable
uptake and processing of the model antigen ovalbumin. Expression of costimulatory
receptors was similar in both types of BMDCs, both at unstimulated state and after
activation with LPS. However, activated KSRP-/- BMDCs showed higher expression levels
for a number of cytokine and chemokine encoding mRNAs than stimulated WT BMDCs. RNA
decay analysis confirmed that KSRP impaired the half life of these mRNA species in
WT BMDCs. Quantitative PCR analysis of immuno-precipitated KSRP-RNA complexes identified
a panel of genuine KSRP mRNA targets. In line with elevated mRNA expression, stimulated
KSRP-/- BMDCs produced cytokines at higher level than WT BMDCs. Ongoing work is focussed
to elucidate the functional consequences of enhanced cytokine production by stimulated
KSRP-/- BMDCs with regard to their T cell stimulatory and polarizing capacity.
Our results indicate that KSRP constitutes a major negative regulator of DC activation
to limit the extent of adaptive immune responses.
V09
Local inhibition of IL-4- and IL-13-mediated signaling as adjuvant for tolerance induction
during allergen-specific immunotherapy
D. Rußkamp1, A. Aguilar-Pimentel2, T. Grunwald3, V. Gailus-Durner2, H. Fuchs2, R.
Bredehorst3, C. Ohnmacht4, M. Ollert5, M. Hrabě de Angelis5, 6, C. Schmidt-Weber4,
S. Blank4
1
Center of Allergy & Environment (ZAUM), Institute of Allergy Research, Member of the
German Center for Lung Research (DZL),Technical University and Helmholtz Center Munich,
Germany;
2
German Mouse Clinic, Institute of Experimental Genetics, Helmholtz Center Munich,
Germany;
3
PLS-Design GmbH Hamburg, Germany;
4
Center of Allergy & Environment (ZAUM), Institute of Allergy Research, Technical University
and Helmholtz Center Munich, Member of the German Center for Lung Research (DZL),
Munich, Germany;
5
Department of Infection and Immunity, Centre de Recherche Public de la Santé (CRP-Santé),
Luxembourg, Luxembourg; 6German Center for Diabetes Research (DZD), Technical University
and Helmholtz Center Munich, Germany
Background: Although specific immunotherapy represents an effective treatment in many
cases, success rates vary and patient compliance is low due to long treatment times.
Our aim is to use an IL4-/IL-13 antagonist (IL-4 mutein) in combination with local
application of adjuvants and allergens applying a biodegradable hydrogel to induce
allergen-specific systemic tolerance via generation of a tolerogenic microenvironment.
Methods: The thermogelling PLGA-PEG-PLGA triblock copolymer-based hydrogel was generated
by means of chemical synthesis. The characteristics of the hydrogel were analyzed
by different methods. The IL-4 mutein was recombinantly produced and its functionality
assessed by various T and B cell differentiation assays.
Results: The synthesized hydrogel showed the desired characteristics and was fluid
at room temperature and in a gelation state at body temperature. Additionally, the
hydrogel was able to build a depot that is stable over several days in vivo. Moreover,
the degradation of the gel in mice and the release of substances were visualized by
magnetic resonance imaging (MRI). The mouse IL-4 mutein was successfully produced
using different recombinant expression systems and it´s functionality could be demonstrated
by dose-dependent inhibition of IL-4-driven proliferation of the established cell
line CTLL-2. Additionally, the IL-4 mutein was able to down regulate IL-4 induced
proliferation and IgE class-switching of mouse spleen B cells. Moreover, IL-4 driven
in vitro differentiation of naive CD4+ T cells into TH2 cells was completely inhibited
by addition of IL-4 mutein as analyzed by FACS.
Conclusion: Taken together our results build the first steps towards the combination
of specific immunotherapy and local T cell modulation applying adjuvant molecules
to create a tolerogenic microenvironment. Moreover, the hydrogel together with different
immune modulators builds a free combinable modular system that might help to shift
immune balance under various pathological conditions.
V10
IPSE/alpha-1, a secreted glycoprotein from Schistosoma mansoni eggs, may inhibit inflammation
K. Knuhr1, M. Doenhoff2, H. Fehrenbach1, H. Haas3, G. Schramm1
1
Forschungszentrum Borstel, Deutschland;
2
University of Nottingham, Nottingham, UK;
3
helminGuard, Sülfeld, Deutschland
Chronic infection with the parasitic worm Schistosoma mansoni is characterized by
a strong anti-inflammatory immune response caused by schistosome eggs. Importantly,
schistosome eggs secrete potent immunomodulatory molecules, including the glycoprotein
IPSE/alpha-1. Previously, we have shown that IPSE/alpha-1 triggers basophils to release
IL-4 and IL-13. These cytokines are well known as key cytokines for Th2 induction
but also as inducers of wound-healing alternatively activated macrophages (AAMs).
Moreover, in schistosome infection, IL-4 and IL-4 receptor signaling plays a crucial
role in preventing excessive lethal intestinal inflammation in mice. This prompted
us to investigate the anti-inflammatory potential of basophil-derived IL-4 following
stimulation with IPSE/alpha-1.
When co-cultured with IPSE/alpha-1-stimulated basophils LPS-activated monocytes acquired
an AAM-like phenotype with decreased production of pro-inflammatory cytokines IL-6,
IL-1β and TNFα. Since immunohistochemical staining of infected murine gut reveals
the presence of basophils in schistosome egg granulomas, we propose that IPSE/alpha-1-triggered
basophil IL-4 turns down and controls schistosome egg-induced inflammatory processes.
We expect that these findings may be translated to new strategies for treating chronic
inflammations such as allergy and autoimmune diseases.
(Funded by DFG-SCHR608/4-1)
V11
IPSE/alpha-1, an immunoglobulin-binding factor from the parasitic worm Schistosoma
mansoni, binds to and is taken up by human B cells
K. Langhans1, S. Nyenhuis1, H. Smits2, H. Fehrenbach1, H. Haas3, G. Schramm1
1
Forschungszentrum Borstel, Deutschland;
2
Leiden University Medical Center, Leiden, The Netherlands;
3
helminGuard, Sülfeld, Deutschland
Infection with the parasitic trematode Schistosoma mansoni protects mice against allergic
airway inflammation. It was reported that regulatory B cells (Bregs) are involved
in this process. However, the mechanism of Breg induction is largely unknown. Previously,
we have identified a glycoprotein secreted from S. mansoni eggs, IPSE/alpha-1, that
triggers the release of IL-4 and IL-13 from basophils via interaction with surface
IgE. Here we show that IPSE/alpha-1 is an immunoglobulin-binding factor that binds
to isolated human CD19+ B cells presumably via the B-cell receptor (BCR) as the binding
can be blocked by anti-IgG/M antibodies. Confocal microscopy revealed that IPSE/alpha-1
is taken up by the B cells and accumulates to a confined area near the nucleus. Preliminary
determination of the cytokine production and surface marker expression did not show
a characteristic profile described for Bregs. Nevertheless, its uptake and its circumscript
perinuclear location suggest that IPSE/alpha-1 has an impact on B cell function.
(Funded by DFG (SCHR608/4-1)
V12
Human IgE is efficiently produced in biologically active form in lepidopteran cells
F. Bantleon1, S. Wolf1, H. Seismann2, M. Miehe1, F. Jabs1, D. Rafei-Shamsabadi3, S.
Dam1, T. Jakob3, M. Plum1, E. Spillner1
1
Aarhus University, Aarhus, Dänemark;
2
Euroimmun AG, Lübeck, Deutschland;
3
University Medical Center Freiburg, Deutschland
The role of specific and high affinity IgE in reacting against minute amounts of allergens
and parasites and to provoke severe anaphylactic reactions renders IgE a mechanistically
outstanding isotype. IgE represents the least abundant serum antibody isotype and
exhibits a variety of peculiarities regarding structure and effector functions. Despite
large progress in antibody technologies however the recombinant access to isotypes
more complex than IgG still is scarce, a consequence of the demands of the immunoglobulins
and the capacity of the expression systems used.
In order to overcome the limitations often posed by mammalian expression systems we
established the recombinant production of IgE in insect cells. Recombinant human IgE
(rIgE) was efficiently assembled and secreted into the supernatant in yields of >30
mg/L. Purification from serum free medium using different means provided large amounts
of rIgE. The rIgE exhibited a highly specific interaction with its antigen, therapeutic
anti-IgE and its high affinity receptor, the FcεRI. Lectins and glycoproteomic analysis
revealed the presence of a prototypic N-glycosylation of the epsilon heavy chain.
Mediator release assays demonstrated the biological activity of the IgE in activating
effector cells in response to trace amounts of antigen. In summary the expression
in lepidopteran cells provide molecular access to IgE of retained characteristics
and biological activity. Our data also contribute to the understanding and potential
use of this important antibody isotype.
V13
Generation of specific Fab antibodies for functional and structural analyses
M. Plum1, T. Raiber2, L. Tjerrild1, M. Miehe1, F. Bantleon1, S. Wolf1, H. Seismann3,
F. Jabs1, T. Jakob4, E. Spillner1
1
Immunological Engineering, Aarhus University, Aarhus, Dänemark;
2
Universität Hamburg, Deutschland;
3
Euroimmun AG, Lübeck, Deutschland;
4
Allergy Research Group, Department of Dermatology, University Medical Center Freiburg,
Deutschland
Background: Addressing the molecular basis of the interplay of the adaptive immune
response remains difficult as the multivalent nature of antibodies and the heterogeneity
of allergens often hamper a detailed molecular dissection. Functional and structural
analyses however demand the availability of specific antibodies in well-defined form.
Objective: Recombinant access to monovalent Fab antibodies for analysis of functionality,
affinity and structure.
Methods: Selected antibodies were converted to Fabs by recombinant fusion with human
IgG1 CH1 and κCL. The Fabs then were produced by baculovirus-mediated infection of
insect cells and purified by affinity chromatography. Functionality and affinity of
resulting antibody fragments was shown by ELISA and SPR analyses.
Results: Fab antibodies could be efficiently expressed as properly assembled and secreted
proteins in Sf9 insect cells with high yields. The proteins could be purified by affinity
chromatography approaches. Resulting specific Fabs showed pronounced reactivities
in ELISA with their particular antigens. The affinities of the monovalent Fab antibodies
were assessed by SPR and compared to those of the full immunoglobulins.
Conclusion: Recombinant production in insect cells is a suitable strategy for high
yield production of specific Fabs and will allow for detailed functional and structural
analyses of the molecular recognition of antibodies and allergens.
V14
Cross-reactivity and Allergenicity Assessment of Therapeutic Monoclonal Antibodies
against TNF-alpha
A. Homann1, N. Röckendorf1, S. Minge1, A. Frey1, A. Kromminga2, U. Jappe1, 3
1
Forschungszentrum Borstel, Deutschland;
2
IPM Biotech, Hamburg, Deutschland;
3
Uni Lübeck, Deutschland
Background: Therapeutic monoclonal antibodies are novel types of drugs with high benefit
for patients but also new side effects during therapy. There is increasing evidence
that biologicals can induce IgE-mediated allergic reactions like exanthema, urticaria
and anaphylaxis. So far, little is known about the allergenic/immunogenic epitopes
on biologicals and their characteristics. There are clinical cases where fatal anaphylaxis
was observed during the application of the biological cetuximab, associated with IgE
to the disaccharide α-GAL. These severe side effects in general lead to a discontinuation
of the treatment and/or the switch to another type of therapeutic antibody. However,
the therapy switch is not always safe and successful.
Methods: In our study, sera from patients treated with TNF-α-binding biologicals were
evaluated positive for anti-biological antibodies by ELISA in routine clinical laboratory
tests (IPM Biotech). These anti-biological-Ig-containing sera were analysed in terms
of anti-biological IgE via immunoblot with different biologicals such as infliximab,
adalimumab and cetuximab as target antigens. To identify the epitopes on these biologicals,
oligopeptide microarray analysis was performed with overlapping peptide epitopes from
the biologicals and the corresponding ELISA-positive patient sera.
Results: ELISA analyses show that sera from patients treated with anti-TNF-α biologicals
contain antibody levels against these biologicals between 2 and 80 µg/ml. Infliximab-positive
sera tested in an adalimumab-ELISA were evaluated negative, showing that there is
no cross-reactivity as determined by ELISA. In an oligopeptide microarray epitope
mapping approach of infliximab-positive patient sera, distinct epitopes were identified
in the variable, antigen-binding region of the biologicals.
Conclusion: Taken together, these analyses shall lead to a knowledge-based allergenicity
and side effect risk assessment of each type of biological and to a safer recommendation
of a therapy switch.
V15
Effective preclinical testing of relevant biologicals in humanized mice
J. Kubach, B. Trinschek, M. Sommer, H. Jonuleit
Hautklinik, Universitätsmedizin Mainz, Deutschland
Our immunologic knowledge is mainly based on analyses of human immune cells in vitro
or on in vivo investigations in mouse models. However, complex biological processes
are often species-specific and differences between mice and man limit the prognostic
value in preclinical testing of novel biologicals for treatment of allergy, psoriasis
or autoimmune diseases. Humanized mice have been developed to overcome these limitations.
They are immunodeficient and allow the transplant of human tissues, patient-derived
immune cells or blood stem cells (HSC). Analysis of such humanized mouse models is
used for preclinical testing of biological drugs leading to identification of functional
mechanisms and important side effects [Kubach et al. Int J Cancer. 2014,doi: 10.1002/ijc.29037].
Here we demonstrate the preclinical analysis of the HIV-1 glycoprotein gp120 as an
efficient polyclonal Treg stimulator that blocks overwhelming T cell activities in
vitro and in vivo. Gp120 activates human Treg by binding and signaling through CD4,
leading to accumulation of cyclic adenosine monophosphate (cAMP) in their cytosol
and functional activation of suppressive capacity. Utilization of gp120 in a xenogenic
humanized mouse model a single treatment with gp120 inhibits strong inflammation of
skin, liver and colon after transfer of human immune cells. Therefore, we are currently
developing novel humanized mouse systems for effective preclinical testing of immunotherapeutic
concepts in order to evaluate the impact of novel biologicals on the restoration of
the immunological homeostasis. These models allow analysis of patient-derived immune
cells in vivo and can be a helpful tool to evaluate the reasons but also feasible
therapies of dysregulated immune responses observed in asthma, allergy and autoimmune
diseases.
V16
The role of tonsillar epithelial E-Cadherin for the control of regulatory T cells
in allergic children
H. Meinicke1, M. Lickert 2, M. Seidl3, H. Pircher4, A. Izcue5, A. Heinzmann2
1
Zentrum für Kinder- und Jugendmedizin Freiburg Klinik I: Allgemeine, Deutschland;
2
Department of Paediatrics and Adolescent Medicine, University of Freiburg, Deutschland;
3
Institute of Pathology, University of Freiburg, Deutschland;
4
Institute of Immunology, University Medical Center Freiburg, Deutschland;
5
Max-Planck-Institute of Immunobiology and Epigenetics; Centre of Chronic Immunodeficiency,
University of Freiburg, Deutschland
All inhalative or oral allergens have to pass the tonsils in the pharynx. Interestingly,
the role of tonsils in the development of allergies or in the tolerance of allergens
is not well investigated, even if there is no question about the tonsils’ role as
first-line defense barrier. In human tonsils but also in other organs Foxp3+ regulatory
T cells (Treg) have been identified as significantly involved in the development of
tolerance and in the formation of immune balance. Recently, there is increasing interest
in the role of Treg subgroups for the control of different forms of inflammation and
infection and former Th2-transcription factor GATA3 seems to play an important role
also in Treg. Moreover, there is a rising focus on the crosstalk of non-immune cells
with immune cells becomes. One molecule of special interest is the adhesion molecule
E-Cadherin which is widespread in all mucosal tissues like the airways or the intestine
but can also be found in human tonsills and Allergens can attack epithelial barriers
by breaking homologous E-Cadherin structures. E-Cadherin has two signaling partners
on immune cells, KLRG1 and CD103 which are also expressed on Treg. We could show in
a mouse model where intestinal N-Cadherin substitutes for E-Cadherin that KLRG1-E-Cadherin
signaling is decisive in two directions: both the lack of E-Cadherin on intestinal
epithelial cells and the KLRG1-knockout on all cells lead to the accumulation of Treg.
In the current project we now want to dissect the importance of epithelial E-Cadherin
for tolerance induction by priming Treg in pediatric tonsils and compare the data
of allergic and non-allergic children. Moreover, the role of Treg subgroups like GATA3+-Treg
in the protection of allergy pathogenesis is a special focus of this project.
V17
Biobanking in Allergology–a new perspective?
P. I. Pfefferle
Comprehensive Biomaterial Bank Marburg CBBM, Marburg, Deutschland
Initially developed to support translational tumor research biomaterial banks are
well-recognized platforms to accomplish scientific approaches in nearly all fields
of medical research. Biobanks contribute to clinical and basic investigations by providing
mainly human liquid and solid biospecimens and their derivates (nucleic acids, purified
cells, supernatants) that were obtained, processed and stored under standardized and
quality-controlled conditions. By offering well-protected donor-specific data sets,
biobanks contribute to a better understanding of disease development and to personalized
medicine approaches that aim to improve therapy on the patient level.
While well-advanced in tumor research biobanks are still in the early stage of development
in allergy research. This is remarkable as translational research is an emerging field
of research in allergology. One step forward, inclusion of biospecimes obtained from
other chronic inflammatory diseases might pave the way towards a better understanding
of basic mechnisms that contribute to an imbalanced immune response and following
autoimmune or allergic conditions.
CBBM is a core facility of the medical faculty and all clinical settings of the Marburg
University Hospital are enroled to recruite donors for the Marburg Biobank. The Marburg
Biobank was established to support the local research focus “Tumor and Inflammation“.
Based on SOP(standard operation procedure)-guided protocols and accomplished by a
LIMS(Laboratory information management system)-based data center, CBBM has developed
a work process to built up tissue-, liquid specimen- and cell banks to collect samples
for the investigation of malignant as well as chronic inflammation conditions. Tissue
samples as well as lavages are prepared to be processed and cryoconserved for further
analyses on the candidate and the -omics-level. In addition, sets of body fluids and
blood cell populations were employed to later determine immune, metabolic, hormonal
and (epi)genetic parameters in these samples.
Respiratory tract
V18
Pollen-derived adenosine plays an important role in induction of ragweed allergy
M. Kamml1, S. Gilles1, U. Frank2, D. Ernst2, J. Winkler3, P. Schmitt-Kopplin4, C.
Ohnmacht5, H. Behrendt5, C. Schmidt-Weber5, C. Traidl-Hoffmann1, J. Gutermuth6, F.
Alessandrini5
1
Institute of Environmental Medicine (UNIKA-T), Center of Allergy and Environment (ZAUM),
Technische Universität and Helmholtz Zentrum München, Munich, Germany;
2
Institute of Biochemical Plant Pathology, Helmholtz Zentrum München, Munich, Germany;
3
Research Unit Environmental Simulation at the Institute of Biochemical Plant Pathology,
Helmholtz Zentrum München, Munich, Germany;
4
Research Unit Analytical BioGeoChemistry, Helmholtz Zentrum München, Munich, Germany;
5
Center of Allergy and Environment (ZAUM), Technische Universität and Helmholtz Zentrum
München, Munich, Germany;
6
Department of Dermatology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel,
Belgium
Background: Adenosine is an important metabolite, which plays a role in inflammation
as well as in immune suppression and regulation. Furthermore it has recently been
shown that adenosine is released from pollen grains, giving rise to speculations of
its possible role in pollen-induced allergic reactions. Aim of the study was to evaluate
the role of pollen-derived adenosine in allergic airway inflammation.
Methods: Mice were instilled intranasally with ragweed extract or ragweed extract
depleted of adenosine and allergic airway inflammation was evaluated. Furthermore,
the effect of adenosine-depletion was assessed separately for the sensitization or
the elicitation phase. In vitro, migration of human eosinophils and neutrophils towards
supernatants of ragweed-stimulated bronchial epithelial cells was analyzed.
Results: Eleven instillations with the total ragweed extract led to strong cell infiltration
into the bronchoalveolar lavage, impaired lung function parameters and a systemic
Th2 response. Depletion of adenosine from the total ragweed extract abrogated the
ragweed-induced local and systemic Th2 responses. As expected, adenosine supplementation
in the adenosine-depleted ragweed extract reestablished the symptoms of allergic airway
inflammation. Interestingly, pollen-derived adenosine showed a protective role in
the sensitization phase, while exacerbating the elicitation phase of the allergic
airway response. In vitro, human eosinophils and neutrophils migrated towards supernatants
of ragweed extract-stimulated bronchial epithelial cells only in the presence of adenosine.
Conclusion: Pollen-derived adenosine is a critical factor in ragweed-pollen induced
allergic airway inflammation. Future studies aim at therapeutic strategies to control
these allergen-independent pathways.
V19
Airway surface dehydration is a novel risk factor for allergic airway inflammation
B. Fritzsching1, 2, L. Dai1, C. van Bodegom1, J. Schatterny1, S. Hirtz1, Z. Zhou-Suckow1,
M. Hagner1, S. Christochowitz1, M. Mall1, 2
1
Abteilung Translationale Pneumologie, Sektion für Pädiatrische Pneumologie und Allergologie,
Translational Lung Research Center, Deutsches Zentrum für Lungenforschung, Universitätsklinikum
Heidelberg, Deutschland;
2
CF-Zentrum, Universitätsklinikum Heidelberg, Deutschland
Introduction: We have previously demonstrated that mice with airway specific overexpression
of the amiloride-sensitive epithelial Na+ channel (βENaC-Tg) and mice lacking the
epithelial Cl- channel SLC26A9 suffer from airway surface dehydration and airway mucus
obstruction, which might be implicated in the pathogenesis of allergic airway disease
(Anagnostopoulou et al., JCI 2012 and Mall et al., AmJRespirCritCare Med 2008). Here,
we hypothesized that airway surface dehydration and reduced mucociliary clearance
may increase the susceptibility for allergic airway inflammation.
Methods:
Aspergillus fumigatus extract (Af) was applied by intratracheal instillations into
juvenile βENaC-Tg mice or WT mice (C57BL/6) and BAL cell counts, IL-13 levels and
airway hyperresponsiveness (AHR, by Flexivent lung function) were determined. Genetic
deletion of the IL-4/IL13 receptor signal transducer STAT6 was introduced to ENaC-Tg
mice to analyze the contribution of type 2 inflammation to the Af immune response.
Furthermore, preventive treatment of βENaC-Tg mice and WT mice with amiloride was
performed and BAL and IL-13 levels were determined.
Results: Airway eosinophils and pulmonary IL-13 expression were significantly increased
in Af-challenged compared to vehicle-treated βENaC-Tg mice. Airway hyperresponsiveness
was elevated in βENaC-Tg mice and increased further in response to Af treatment. Genetic
deletion of STAT6 abrogated Af-induced airway eosinophilia and IL-13 expression in
ENaC-Tg mice. Preventive treatment with amiloride significantly reduced allergic inflammataion
in both βENaC-Tg and WT mice.
Conclusion: Collectively, our results indicate that airway surface dehydration is
a risk factor for key pathologies in allergic airway disease. Amelioration of airway
surface dehydration (i.e. by amiloride) might constitute a novel target for prevention
and treatment of allergic airway disease.
Acknowledgements: DFG (DFG MA 2081/3-2)
V20
Inflammatory effect of wheat alpha-amylase/trypsin inhibitors (ATIs) on murine allergic
airway activation
V. Zevallos1, V. Raker2, J. Maxeiner3, P. Scholtes3, K. Steinbrink2, D. Schuppan1
1
Institute of Translational Immunology and Research Center for Immunotherapy (FZI),
Univ. Medical Center, Johannes Gutenberg University Mainz, Germany;
2
Department of Dermatology, Univ. Medical Center, Johannes Gutenberg University Mainz,
Germany;
3
Asthma Core Facility, Research Centre Immunology (FZI), Univ. Medical Center, Johannes
Gutenberg University Mainz, Germany
Introduction: Wheat alpha-amylase/trypsin inhibitors (ATIs) are non-gluten proteins
that activate innate immunity via the toll like receptor 4 (TLR4)-MD2-CD14 complex
in cells of the mononuclear phagocyte system (Junker Y et al, J Exp Med 2012). ATIs
are also present in gluten preparations and are implicated as additional pathogenic
triggers of celiac disease (CD) and other autoimmune and inflammatory diseases.
Aim and methods: We investigated the effects of dietary ATIs on allergic airway inflammation.
Female C57BL/6 mice on a gluten-free diet (GFD) were sensitised and challenged with
ovalbulmined (OVA). Animals were divided in 5 groups: 1. continued with the GFD and
mock-sensitised with PBS, 2. continued with the GFD and sensitised with OVA, 3. changed
to a diet containing 25% gluten (containing amounts of ATIs equivalent to the human
wheat based diet), 4. changed to a diet containing purified ATIs, and 5. changed to
a diet containing 25% gluten de-enriched of ATIs. We measured invasive lung function,
bronchoalveolar lavage (BAL), proliferation of OVA stimulated splenocytes and histological
sections of lung with Hematoxylin and eosin(HE) and Periodic acid–Schiff (PAS)
Results: Mice on a GFD sensitized with PBS did not develop airway hyperreactivity
(AHR) after local provocation with OVA. Interestingly, mice on a GFD or on a diet
containing 25% gluten de-enriched of ATIs and sensitized with OVA developed a reduced
AHR compared to mice fed the pure ATIs rich diet or 25% gluten (plus ATI) diet. Similar
results were observed for eosinophilic infiltration in BAL (HE) and mucus production
(PAS) in the lung
Conclusions: We demonstrate that dietary ATIs enhance allergic airway inflammation
in OVA- challenged mice, GFD (ATI-free) diet appears to have a protective effect on
AHR and gluten depleted of ATIs has a reduced stimulatory effect compared with gluten
containing ATIs or ATIs alone. Therefore, ATIs appear to be major and clinically relevant
nutritional triggers of innate immunity fuelling allergic airway inflammation.
V21
Deletion of the α1 isoform of soluble Guanylyl Cyclase interferes with allergic response
in a murine model of chronic asthma
S. Köhler-Bachmann, E. Mergia, A. Bufe, D. Koesling
Ruhr Universität Bochum, Deutschland
Background: The soluble Guanylyl Cyclases (sGC) are widely distributed nitric oxide
(NO)-dependent cyclic guanosine 5´-monophosphate (cGMP)-generating enzymes which beside
others regulate smooth muscle tone and exert anti-inflammatory effects. sGCs are obligate
heterodimers, composed of α and β subunits. The sGCα1β1 is the most prevailing form
in the lung and its expression is downregulated in asthma. To date mainly local pharmacolocigal
intervention of the sGC/cGMP signaling was performed to address its impact on bronchial
hyperreactivity and inflammation. In this study we use α1sGC knock out mice in a chronic
model of asthma to illuminate the isoform-specific impact of sGCs on the pathology
of asthma in the mouse.
Methods and Results: For the asthma model, wildtype (WT) and α1sGC knock out (KO)
mice were sensitized and then challenged with ovalbumin for 8, 12 and 15 weeks, respectively.
Asthmatic phenotype was determined by analysis of the bronchoalveolar lavage (BAL)
and serum, histology and airway hyperresponsiveness (AHR) to inhaled methacholine.
OVA treated WTs clearly show AHR, inflammation and the characteristic histological
changes of airway remodeling after 8 and 12 weeks with decreasing signs of inflammation
after 15 weeks. At the same time points the KOs show a significant lower Th2 response
whereas AHR and submucosal fibrosis in the KOs do not differ from WTs.
Discussion: Our results show that α1sGC-definciency interferes with the allergic cascade.
This might originate from a limited antigen presenting capacity of the antigen presenting
cells (APCs) or impaired migration of eosinophils. However, thickening of the reticular
basement membrane is not altered. This indicates a α1sGC dependent and partially inflammation-independent
profibrotic process. Furthermore the absence of α1sGC does not aggrevate the AHR in
either treated or untreated animals suggesting that other than α1sGC-dependent mechanisms
regulate bronchial relaxation.
V22
Analysis of sensitization patterns against classical allergens and pathogen-specific
IgE in patients with cystic fibrosis
A.-M. Dittrich1, M. Albrecht1, S. Dzoro3, C. Dopfer1, S. Junge1, A. Sauer-Heilborn1,
B. Hales3, R. Valenta2
1
Pediatric Pneumology, Allergology and Neonatology, Hannover Medical University, Hannover,
Germany;
2
Medical University of Vienna, Vienna, Austria;
3
The University of Western Australia, Perth, Australia
Background: IgE-production directed against facultative airway pathogens such as Staph.
aureus, Pneumococci, H. influenza and Aspergillus species has been described in different
chronic lung diseases. In the context of bronchial asthma, increases in pathogen-directed
IgE titres accompany exacerbations of steady-state and have been associated with the
development of IgE-production against classical allergens. Such associations are lacking
for other chronic lung disease where similar studies have not yet been performed.
Hypothesis: Sensitization patterns against bacterial, fungal and classical allergens
correlate in a disease-specific manner with the development, chronification and exacerbation
of different chronic inflammatory lung diseases and influence the course of infections
with facultative pathogenic organisms.
Methods: IgE against Staph. aureus and E. coli were detected by immunoblotting, IgE
against H. influenza and Pneumococci were detected by DELFIA, IgE against 176classic
allergens were assessed by an allergen chip. Sensitization (IgE and IgG) against Aspergillus
were assessed via commercially available CAP-systems. Microbial colonization was assessed
by standard microbiological culture techniques.
Results: We collected sera from 35 patients with CF and increased total IgE levels.
Analysis of our patient samples revealed very distinct sensitization patterns. Correlations
between sensitization against classical allergens and pathogen-specific IgE as well
as microbial colonization status and clinical parameters were performed.
Outlook: These analyses will have to be extended to more patients, sequential measurements
and other lung diseases. They will provide insight into the complex interplay between
microbial colonization and allergic sensitization and promise to identify allergen-specific
IgE production as easily accessible biomarkers for different chronic lung diseases.
V23
House dust mite-specific sublingual immunotherapy prevents allergic inflammation development
in mice
H. Garn1, S. Hagner1, C. Rask2, H. Raifer3, H. Renz1
1
Institute of Laboratory Medicine and Pathobiochemistry – Molecular Diagnostics, Center
for Tumor- and Immunobiology (ZTI), Medical Faculty, Philipps University of Marburg,
Marburg, Germany;
2
Experimental Immunology, ALK-Abello, Horsholm, Denmark;
3
Institut für medizinische Mikrobiologie und Krankenhaushygiene, Medical Faculty, Philipps
University of Marburg, Germany
Background: Sublingual immunotherapy (SLIT) is a disease-modifiying treatment for
respiratory allergies. Evidence regarding SLIT efficacy and its good safety profile
has made it an attractable treatment option also for allergic asthma. The majority
of studies have focused on grass pollens; however, data regarding efficacy for other
allergens, like house dust mite are now available. Nevertheless, the underlying immunological
mechanisms still remain only partially understood.
Objectives: To establish a house dust mite (HDM) SLIT model and investigate local
immunological changes.
Methods: Balb/c mice were i.n. sensitized/challenged with a HDM extract. HDM SLIT
was performed in advance of (prophylactic) the induction of an allergic airway inflammation.
Lung inflammation and airway hyperresponsiveness were assessed by bronchoalveolar
lavage cell counts, lung histology and flexivent measurement, respectively. Humoral
and cellular immune responses were monitored in serum, lung and BALF by ELISA and
FACS-analysis.
Results: Prophylactic sublingual administration of HDM prevents the recruitment of
leukocytes, (mainly eosinophils and neutrophils) and airway hyperresponsiveness (resistance)
as well production of the TH2 cytokines IL-5 and IL-13 in re-stimulated lymph nodes.
No effects on the immunoglobulin titer were observed. FACS-analysis of the lung T
cell compartment revealed an involvement of CD4-CD8- γδ-T cells and CD8+CD25+IFN-γ+
cells in regard to the underlying mechanism.
Conclusion: A clinical relevant HDM animal model may be useful to further elucidate
the efficacy and mechanisms of HDM SLIT against asthma.
V24
Functionalized nanoparticles target B cells in vivo due to their opsonization with
complement and are suitable for allergy immunotherapy
L. Shen1, I. Tubbe1, E. Montermann1, V. Raker1, J. Maxeiner2, S. Reuter3, M. Bros1,
S. Grabbe1
1
Department of Dermatology, University Medical Center Mainz, Germany;
2
Asthma cofacility, University Medical Center Mainz, Germany;
3
III. Medical Clinic, University Medical Center Mainz, Germany
The vast potential of nanoparticles as carriers for antigen and immunmodulatory drugs
for vaccination has been well acknowledged. Cell type specific delivery of nanomedicine
constitutes a major aim of current research. For this, nanoparticles are conjugated
with derivatives of natural ligands or cell receptor-specific antibodies. Many approaches
focus on the targeting of so-called antigen presenting cells and among these dendritic
cells (DCs) as potent inducers of primary T cell responses. In contrast, despite their
important role as inducers of humoral immune responses, B cells have received little
attention so far.
Here we show that dextran-coated ferrous oxide nanoparticles (Fe-NPs) are opsonized
by complement, which in turn facilitates specific binding to B cells via complement
receptors CR-1/2. In order to exploit their intrinsic B cell targeting property for
the induction of an antigen-specific antibody response, Fe-NPs were coated with ovalbumine
(OVA) as a model antigen and immunostimulatory CpG oligonucleotides (ODN). When injected
into naive C57BL/6 mice, Fe-NPs elicited a robust Th1-biased antibody response as
reflected by high IgG2a and concomittantly low IgG1 serum levels. In therapeutic OVA-dependent
anaphylaxis and asthma models, only particles conjugated with OVA and CpG inhibited
IgE production, attenuated bronchial hyper responsiveness and lung inflammation (asthma),
and promoted survival (anaphylaxis).
To the best of our knowledge this report is the first to demonstrate B cell specific
targeting of a nanoparticle in a se-rum-dependent manner and serve as nanomedicines
for the treatment of infections and other diseases which require the induction of
a strong humoral immune response.
V25
Potential anti-inflammatory and anti-viral effects of Petasites hybridus (butterbur
extract) on primary human nasal epithelial cells in vitro
S. Steiert1, A. Chaker2, U. Zissler1, H. Bier2, J. Drewe3, C. Zahner3, C. Traidl-Hoffmann4,
5, C. Schmidt-Weber1, S. Gilles4
1
Zentrum Allergie & Umwelt, Technische Universität und Helmholtz-Zentrum München, Deutschland;
2
HNO-Klinik, Klinikum rechts der Isar, Technische Universität München, Deutschland;
3
Max Zeller Söhne AG, Romanshorn, Schweiz;
4
Institute of environmental medicine, UNIKA-T, Klinikum rechts der Isar, Technische
Universität München, Deutschland;
5
CK Care, Christine Kühne Center of Allergy Research and Education, München, Deutschland
Background: As integral part of the innate immune system, nasal epithelial cells are
involved in early steps of allergic inflammation and defence against respiratory infections.
A CO2 extract of butterbur leaves (Tesalin) has been clinically shown to improve congestion
in allergic rhinitis and reduce IL8 secretion, however the mode of action remains
unclear.
Aim of study: To evaluate the anti-inflammatory effect of butterbur leaf extract for
potential topical application in allergic and non-allergic, acute rhinitis/rhinosinusitis
and to elucidate its mechanism of action in nasal epithelial cells.
Methods: Human primary nasal epithelial cells were obtained from turbinoplastic surgeries.
Cells were stimulated with the viral mimicks (PolyIC:TLR3, PolyIC-LyoVec:RIG-1/MDA5,
CpG:TLR9), bacterial TLR ligands (Pam3CSK4:TLR1/2, Flaggellin: TLR5). Stimulation
occurred either alone or in combination with Tesalin. Readouts were production pro-inflammatory
cytokines and chemokines (IL8, GCSF, CCL3, CCL4, CCL5, CXCL10, IL6, TNFa, IL1a) and
neutrophil chemotaxis towards stimulated supernatants.
Results: Stimulation of human nasal epithelial cells with the TLR3 ligand PolyIC leads
to the release of proinflammatory cytokines and chemokines and induced neutrophil
chemotaxis towards cell supernatants. Tesalin reduced the PolyIC-induced production
of proinflammatory cytokines and chemokines. Reduction of IL8 was paralleled by significantly
decreased neutrophil chemotaxis towards supernatants of PolyIC/Tesalin-treated cells.
In addition, Tesalin influences the regulation of RIG-1/MDA5, TLR9 and TLR3, but not
TLR1/2 and TLR5, when stimulated with the different ligands of these receptors.
Conclusion: Besides its clinical benefit in allergic rhinitis, our data imply that
Tesalin might be an effective treatment for non-allergic rhinitis and rhinosinusitis.
Of note, Tesalin seems to specifically target virally triggered pathways in human
nasal epithelial cells, suggesting potent anti-viral potential of the herbal drug
in topic application.
V26
Wnt-1 treatment prevents inflammation in the mouse model of allergic airway disease
H. Beckert, C. Belz, A. Heinz, H. Meyer-Martin, R. Buhl, S. Reuter
III. Medizinische Klinik, Universitätsmedizin Mainz, Deutschland
Introduction: Recent publications reveal an anti-inflammatory function of the Wnt-1-induced
β-catenin signaling in allergic airway disease. Binding of secreted Wnt-1 to its receptor
(Frizzeld) and co-receptor (e.g. LRP5) leads to an intracellular accumulation of β-catenin.
Afterwards β-catenin translocates to the nucleus and activates specific gene expression
via the TCF/LEF transcription factor.
We could previously show that overexpression of lung specific Wnt-1 attenuates experimental
allergic airway disease (Reuter, JI, 2014). This effect seemed to be independent of
regulatory T cells (Treg) or IL-10 but was linked to the suppression of DC migration
and there capacity to activate T cells in vivo and in vitro. The aim of this study
was to investigate Wnt-1 as a treatment option for allergic airway disease.
Method: C57BL/6 mice were sensitized intraperitoneally with Ovalbumin/Aluminium hydroxide
on days 0 and 14. For induction of allergic airway disease mice were challenged via
the airways by nebulization with a 1% OVA solution on days 28–30. Some mice received
intranasal Wnt-1 treatment one hour prior to allergen challenge. At day 32 airway
inflammation was quantified by measurement of lung function, lung histological staining,
flow cytometry of lung and draining lymph nodes and analysis of cytokine secretion
of restimulated cells.
Results: The application of Wnt-1 leads to a significant reduction of airway hyperresponsiveness,
inflammation and goblet cell metaplasia. Changes of Treg cells were not detectable
in the lung and lymph nodes. Furthermore, the number of DC remains equally, but the
ratio of subtypes changed to a more Ly6C- CD11b- CD103+ phenotype. Hence, the activation
of the β-catenin signaling pathway by intranasal application of Wnt-1 leads to a reduced
allergic airway inflammation and offers new therapeutic options for the treatment
of allergic diseases like asthma.
V27
CD4-mediated activation of human regulatory T cells for treatment of allergic diseases
M. Sommer1, J. Kubach1, H. Martin2, B. Trinschek1, H. Jonuleit1
1
Hautklinik, Universitätsmedizin Mainz, Deutschland;
2
III. Medizinische Klinik und Poliklinik, Universitätsmedizin Mainz, Deutschland
Regulatory T cells (Treg) play a critical role for maintenance of peripheral immunologic
tolerance. Inefficient Treg function is associated with the development of allergic
diseases. To restore the immunological balance in patients with allergy, we are developing
biological drugs for functional activation of endogenous Treg. We have shown that
human Treg can be activated by a polyclonal CD4-mediated mechanism, without affecting
the activity of CD4+ T helper cells. One candidate (BT-061/Tregalizumab) is now in
clinical trials (psoriasis, rheumatoid arthritis). A second promising candidate is
HIV-1 envelope protein gp120 which we are developing for clinical application. We
have shown, that gp120 activates polyclonally human Treg and efficiently inhibits
the inflammatory symptoms of asthma in a humanized mouse model of allergic asthma
(Martin et al. JACI.). However, this effect was Treg-dependent as gp120 did not affect
the immunological reaction in the absence of Treg. Treatment with gp120 prior to challenge
reduced infiltration of human immune cell into the lung tissue and abrogated the development
of airway hyperresponsiveness.
Since patients with allergic diseases are treated with standard medications, that
have the risk of adverse reactions and sometimes show reduced efficacy, the use of
biological drugs for induction of Treg-mediated tolerance is a more efficient approach.
In addition, not only the successful treatment of established allergy but also the
development of a prophylactic approaches is of great importance. Here we already could
show that next to the therapeutic benefit, the application of gp120 represents a prophylactic
approach as well.
Next to the treatment of allergic airway inflammation other autoimmune disorders like
psoriasis and rheumatoid arthritis are potential indications. Furthermore, gp120 would
encounter a great unmet medical need in the field of the prevention of transplant
rejection.
V28
GARP reduces allergic airway inflammation in a clinical relevant humanized mouse model
H. Meyer-Martin1, S. Hahn2, H. Beckert1, C. Belz1, A. Heinz1, J. Maxeiner4, P. Scholtes3,
C. Taube4, R. Buhl1, C. Becker2, H. Jonuleit2, S. Reuter1, A. Tüttenberg2
1
Pneumologie, III. Med. Klinik, Universitätsmedizin Mainz, Deutschland;
2
Dermatologie, Universitätsmedizin Mainz, Deutschland;
3
Asthma Core Facilitiy, Universitätsmedizin Mainz, Deutschland;
4
Pulmonology Department, University Medical Center Leiden, Niederlande
Glycoprotein A repetitions predominant (GARP) is an activation marker on the surface
of human regulatory T cells (Treg). We have recently shown that a soluble derivate
(sGARP) has strong anti-inflammatory and regulatory properties in vitro as well as
in vivo (Hahn, Blood, 2013). sGARP represses proliferation and cytokine production
of naïve and resting CD4+ T helper cells and induces CD4+ Treg. Furthermore, sGARP
prevents inflammation in a preclinical in vivo humanized mouse model of graft versus
host disease (GvHD).
Because modulation of Treg responses could also have therapeutic effects in other
inflammatory diseases, aim of this study was to investigate the impact of sGARP in
treatment of allergic airway diseases using a humanized mouse model (Martin, JACI,
2012). To address this question, adult NOD/Scid γc-/- mice received peripheral blood
mononuclear cells (PBMC) from a birch pollen allergy sufferer.
To analyze the effects of sGARP, additionally Treg alone or in combination with sGARP
were transferred into the animals. Twenty days following cell application the allergic
airway disease was induced by a three-day intranasal challenge with birch pollen allergen.
48 hours after last challenge allergic inflammation was assessed by measurement of
airway hyperresponsiveness (AHR), quantification of cells in the bronchoalveolar lavage
(BAL) and analysis of human immune cells in different tissues by flow cytometric and
histological staining.
In comparison to mice that received Treg alone, additional transfer with sGARP significantly
reduced AHR, total human immune cell counts, neutrophils and macrophages in the BAL
and human CD4+ T cells in the lungs. Furthermore, number of mucus producing goblet
cells was reduced upon sGARP injection. Hence, amplifying of Treg cell function via
sGARP seems to be a promising treatment option for allergic airway diseases.
Skin
V29
Superior suppressive capacity of skin Tregs compared to lung Tregs in a murine model
of epicutaneous priming
S. Mahapatra1, M. Albrecht1, A. Baru2, T. Sparwasser2, A. Dittrich1
1
Department for Pediatric Pneumology, Allergology and Neonatology, Medical School Hannover,
Germany;
2
Institute of Infection Immunology, TWINCORE, Centre for Experimental and Clinical
Infection Research, Hannover, Germany
We have previously shown that a Th2-polarized airway inflammation can facilitate priming
to new antigens in the lungs which we call “collateral priming”. To investigate whether
an allergic skin inflammation can also facilitate priming towards new antigens, we
established an murine allergic skin inflammation model in analogy to an allergic lung
inflammation model.
Mice were sensitized intraperitoneally towards ovalbumin as primary antigen. Challenge
was performed intranasally or epicutaneously with ovalbumin (OVA) and a secondary
antigen, keyhole limpet hemocyanine (KLH). Re-challenge consisted of local application
of either antigen alone. Analysis of KLH-specific antibody responses, KLH-specific
cytokines by means of ELISA and local inflammation demonstrated tolerance induction
towards the secondary antigen in the skin, whereas in the lung priming took place.
Flow cytometric analysis revealed increased numbers of Tregs, increased CTLA-4 expression
and an enhanced suppressive capacity of Tregs from skin-draining lymph nodes compared
to Tregs from the lung-draining lymph nodes.
These results demonstrate crucial local differences in Treg function in skin vs. lungs
upon repetitive antigen contact which decisively shape the immune response towards
new antigens.
V30
A case of severe anaphylactic reaction following topical application of an herbal
ointment
C. Pföhler, A. Merkoureas, T. Vogt
Saarland University Medical School, Department of Dermatology, Homburg/Saar, Germany
We present the case of a 10-year old boy who suffered a serious episode of an anaphylactic
reaction after topical application of an herbal ointment (Kytta Salbe). This ointment
was applied for aching muscles on the back. Only a few minutes after application he
developed an urticarial skin reaction on the whole back attended and followed by abdominal
pain, generalized urticaria, shivering, numbness, dyspnea and twitching of the eyelids.
Emergency treatment with corticosteroids and antihistamins led to complete remission
of the symptoms within two days. Skin prick testing with single ingredients of the
ointment provided by the manufacturer showed urticarial reaction against the whole
ointment and its ingredient phenonip. All other single ingredients were negative.
Additional testing of parabens and further preservatives was completely negative.
Skin prick testing with grass, tree and herbal pollen and with house dust mites and
cat epithelia was negative as well. Phenonip is a broad spectrum antimicrobial agent
comprising a synergistic blend of esters of para-hydroxybenzoic acid (parabens) in
phenoxyethanol designed for preservation of a wide range of cosmetics and toiletries.
Furthermore, it can frequently be found in ink pens and in medical vaccines. Usually
allergic reactions against phenonip or its components phenoxyethanol and parabens
are late type allergies that results in allergic contact eczema. This is one of the
rare cases in which phenoxyethanol led to the development of contact urticaria followed
by a systemic anaphylactic reaction. To our knowledge only three cases have been published
so far. It must remain unclear what product led to the acquirement of the sensitization
against phenonip, as this ointment had been applied for the first time. Possibly,
phenoxyethanol containing vaccines had been etiological.
V31
IgE-specific immunoadsorption as new treatment option for atopic dermatitis
J. Wegner, C. Stanger, S. Grabbe, J. Menke, E. von Stebut
Department of Dermatology, University Medical Center Mainz, Germany
Immunoglobulin E (IgE) plays a major role in the pathophysiology of atopic predisposition,
although its role in atopic dermatitis (AD) is not fully understood. Anti-IgE treatment
with omalizumab has become available and was approved for treating asthma and urticaria.
However, application of omalizumab in patients with asthma and concomitant AD led
to varying results on AD disease activity. Immunoadsorption (IA) has been used in
AD using either specific depletion of IgE and/or in combination with IgG adsorption.
We now assessed the effects of IgE-specific IA (IgE-IA) on quality of life and disease
activity in severe AD.
We analysed 4 patients that received IgE-IA. All of them suffered from severe AD with
score-points ranging from 34 to 87 (SCORAD) and from 14 to 51 (EASI). Patients had
received different treatments for AD before according to guideline recommendations
without sufficient control of disease. As add on therapy, all patients received 5
2-day treatment cycles of IgE-IA within 10 weeks every 2 weeks. IgE levels, disease
activity (SCORAD/EASI) and quality of life (DLQI, wellbeing five) were monitored before
every IA.
All patients had highly elevated basal total serum IgE levels (range 1.352-23.553kU/l).
The mean reduction of circulating IgE for all 5 cycles of all 4 patients was 85% (range
82-90%). However, within the treatment-free interval, IgE levels raised significantly
again. Disease activity after all 5 cycles was strongly reduced in all 4 patients
(mean 48%, range 27-66% as assessed by SCORAD, and mean 80%, range 69-89% in EASI).
In line, the quality of life was improved by 55% (DLQI, range 21-71%) and by 81% (wellbeing
five, range 17-200%).
In summary, our preliminary results in a small patient collective prove a reliable
and dramatic reduction of the total IgE level in serum during IA associated with reduction
of disease activity and improvement of the quality of live. Despite disappointing
results of anti-IgE treatment in AD, IgE-IA might be highly beneficial for patients
with severe AD
V32
Proteomic patterns in chronic hand eczema
S. Molin1, J. Merl-Pham2, S. Hauck2
1
Klinik und Poliklinik für Dermatologie und Allergologie der LMU, München, Deutschland;
2
Research Unit Protein Science, Helmholtz Zentrum München, German Research Center for
Environmental Health (GmbH), Neuherberg, Deutschland
Background: Chronic hand eczema (CHE) is a frequent skin disease and has a high socio-economic
impact. Pathogenesis of CHE is multifactorial and depends on exogenous factors such
as chronic irritant damage or contact allergy and on endogenous factors such as an
atopic predisposition. In many patients, however, factors triggering the eczema cannot
be clearly identified, or potential triggers cannot explain the clinical presentation.
Objectives: Pathogenetic processes are often reflected by variations in protein expression.
Little is known about protein expression patterns in the skin of patients with CHE.
We therefore set out to systematically and comprehensively analyze the differential
protein expression in CHE using modern mass spectrometry.
Methods: We analyzed palmar skin from hand eczema patients and healthy volunteers
by performing LC-MS/MS analyses and label-free quantification. Subsequently, results
were confirmed by immunohistochemistry of palmar skin from a separate cohort.
Results: In total, we were able to identify 185 candidate proteins that were significantly
differentially expressed in the CHE samples. A detailed analysis of the mass spectrometric
results revealed a characteristic proteomic pattern of epidermal barrier components
and keratinocyte differentiation in CHE. Immunohistochemistry confirmed these findings.
Conclusions: Our results provide important clues to molecular factors and signaling
pathways involved in the pathogenesis of chronic hand eczema.
V33
How to address the functional role of innate lymphoid cells in TNCB contact hypersensitivity
D. Ali Rafei-Shamsabadi, S. van de Poel, S. Kunz, S. Martin, T. Jakob
Allergy Research Group, Department of Dermatology, University Medical Center, Freiburg,
Germany
Background: Innate lymphoid cells (ILCs) can be classified into three groups based
on their dependency on transcription factors and expression of cytokines. The role
of ILCs in the effector phase of allergic contact dermatitis has not been addressed
so far. We have identified all groups of ILCs in ear skin, skin-draining lymph nodes
(SDLN), blood and spleen of wild type mice. Using the contact hypersensitivity (CHS)
mouse model we demonstrated that NK cell- and ILC2 numbers increase in the ear skin
24 h after sensitization and elicitation of CHS with the contact allergen TNCB. Dermal
ILC2 show an activated phenotype.
Aim: We want to evaluate the functional relevance of ILCs in both phases of CHS using
targeted antibody depletion of ILCs and an adoptive transfer model.
Methods: For depletion of ILCs T-cell deficient Rag1-/- mice (CD90.2 genotype) were
treated i.p. 4x with a CD90.2 specific monoclonal antibody. For adoptive transfer
naïve donor mice (CD90.1 genotype) were sensitized with TNCB. After 5 days T-cells
were FACS-sorted from SDLN and adoptively transferred i.v. in Rag1-/- mice (CD90.2
genotype). After transfer mice were challenged with TNCB on the ear skin and effective
transfer of the CHS reaction was measured by increase in ear thickness.
Results: ILCs were efficiently depleted in the blood, spleen and SDLN using the above
mentioned depletion protocol. Transfer of total lymph node cells or sorted T-cells
into RAG1-/- mice was successful and significant hapten-induced ear swelling could
be detected time dependent after the hapten challenge regardless of whether T cells
were transferred one hour or three weeks prior to the challenge. Transferred lymph
node cells showed hapten-specific proliferation in vitro.
Outlook: Given the efficient antibody mediated depletion of ILCs and the successful
adoptive transfer of the hapten specific CHS in RAG1-/- mice, this approach should
now allow us to address the functional role of ILCs during the elicitation phase of
CHS.
V34
Mouse models of chemically induced scleroderma show differences in early skin infiltration
V. Raker1, Y. Kim2, N. Lorenz1, T. Schmidt1, D. Schuppan2, K. Steinbrink1
1
Department of Dermatology, University Medical Center, Mainz, Germany;
2
Institute of Translational Immunology, University Medical Center, Mainz, Germany
The cellular and molecular events resulting in fibrosis development in scleroderma
patients are not fully understood. While a multitude of data have been reported in
terms of T cell and mast cell activation in the late phase of tissue fibrosis, the
specific contribution of antigen presenting cells like dendritic cells and macrophages
in the early phase of fibrosis induction remains unaddressed. For induction of fibrosis
bleomycin and HOCL were administered s.c. in the neck area every day and skin punches
were analyzed for quantification of skin thickness, collagen deposition, myofibroblast
activation (α-SMA), inflammatory infiltrate (HE, flow cytometry) and for expression
of inflammation and fibrosis related mediators (qRT-PCR).
At day 28 both models resulted in a significant increase in dermal thickness, total
collagen levels and a prominent appear-ance of collagen fibers compared to PBS-treated
control animals. Mice injected with HOCl exhibited the most prominent skin thickness
vs. the bleomycin-treated animals which was accompanied by a thick layer of subdermal
fat in the HOCl-group. Histological analysis revealed an increase in cellular infiltrates
in both Scl models which were characterized by using 7-color flow cytometry for DC
and macrophage markers.
Infiltrates peaked at day 7 in bleomycin-/ HOCl-treated skin, decreased and were absent
at day 28 of continuous bleomycin or HOCl application. There was a significant increase
in the number and percentage of CD11b+MHCII+ cells in the HOCl-model which points
to an activated antigen presenting myeloid cell population. In addition, the percentage
of CD11c+MHCII+ representing mostly DC and of Ly6C+MHCII+ and F4/80+MHCII+ monocytes/
macrophages was significantly elevated in the skin of HOCl-injected animals. In both
models, we found upregulated profibrotic parameters with a prominent induction of
procollagen α1(I) in HOCl- and preferential development of α-SMA in bleomycin-treated
mice.
V35
Proinflammatory human slanDCs recruitment by immune complexes
F. Olaru, T. Döbel, A. Lonsdorf, A. Enk, K. Schäkel
Universitäts-Hautklinik Heidelberg , Deutschland
There are a number of pathologic conditions where immune complex (IC) deposition causes
Fc receptor-dependent inflammatory lesions, such as lupus nephritis or cutaneous vasculitis.
6-sulfo LacNAc dendritic cells (slanDCs) are equipped with a unique capacity to bind
IC via the two IC receptors CD16 and CD32. slanDCs circulate in blood at high numbers,
have an outstanding capacity to produce IL-12, IL-23, TNF-α and IL-1β, and can be
found as inflammatory dermal DC in psoriasis and lupus erythematosus (LE).
In this study we provide strong evidence for the molecular and functional specialization
of slanDCs as proinflammatory cells in LE-nephritis and cutaneous vasculitis. Histological
studies revealed a strong accumulation of slanDCs in lesions with dense IC deposition,
e.g. in the glomerulus from LE-nephritis patients and in the intra-/perivascular areas
from cutaneous vasculitis patients.
To investigate the ICs-mediated slanDCs recruitment capacity, we applied a perfusion
assay-based approach coupled with time-lapse video microscopy and measured the arrest
functions of purified leukocyte subtypes on immobilized ICs. The flow conditions were
adjusted to provide physiologically relevant surface shear stress of human venous
capillaries. Under these conditions we observed a pronounced recruitment of FcγRIII
(CD16) positive slanDCs which was completely dependent on CD16.
In a translational in vivo approach, immunodeficient Nonobese diabetic (NOD)-SCID
interleukin-2 gamma chain receptor (NSG) mice were intravenously injected with preformed
ICs and subsequently with fluorescent labeled slanDCs. Using Fc receptors blocking
monoclonal antibodies, we show that glomerular deposition of ICs mediates recruitment
of human slanDCs in a CD16-dependent manner.
Collectively, our findings demonstrate the IC capacity to recruit circulating slanDCs
in vitro and in vivo. Modulation of ICs-mediated slanDCs recruitment may offer therapeutic
benefits in patients with IC-mediated inflammatory and/or autoimmune diseases.
Food
V36
Anaphylactic reaction against amaranth in a cereal
A. Merkoureas, T. Vogt, C. Pföhler
Saarland University Medical School, Department of Dermatology, Homburg/Saar, Germany
We report the case of a 43-year old female who developed two episodes of anaphylactic
reactions after consumption of a breakfast including milk, oatmeal, fresh apples,
strawberries and amaranth. She was eating breakfast in this composition for several
months. In both cases she developed generalized urticaria, dyspnea and circulatory
collapse within several minutes after meal. Emergency treatment with corticosteroids
and antihistamins led to complete remission of symptoms within two hours. Her medical
history was negative for any allergic reaction, she was not suffering from hayfever
or asthma. There was no history of atopic eczema. Skin prick testing showed reactions
to tree, grass and herbal pollen and amaranth. Prick testing with other ingredients
of the cereal was completely negative. Serological investigation showed normal values
for total IgE and basal serum tryptase. Slightly raised specific IgE antibodies could
be detected against grass, tree and herbal pollen. No specific IgE was found for milk,
rye, wheat, millet, rice, buckwheat, sesame, apple and strawberry. Amaranth is a cosmopolitan
genus of annual or short-lived perennial plants. Some amaranth species are cultivated
as leaf vegetables, cereals, and ornamental plants. To this day, amaranth grains are
toasted much like popcorn and mixed with honey, molasses or chocolate or are added
in cereal mixtures. In 2013 the first case of an anaphylactic reaction after consumption
of amaranth grains has been published. This allergy therefore seems to be very rare.
There seems to be no cross-reaction of amaranth seed extract and pollen, however knowledge
concerning this allergy is limited. Furthermore, there is a multiplicity of amaranth
species with a different composition of possible allergens. As the addition of amaranth
to different cereals is increasing as a kind of fashion trend in nutrition, amaranth
allergy should be kept in mind as a possible elicitor of anaphylaxis.
V37
Isolation and characterization of different peanut oleosins: New tools for component-resolved
diagnosis of peanut allergy.
C. Schwager1, S. Kull1, F. Schocker1, W. Becker1, U. Jappe1, 2
1
Division of Clinical and Molecular Allergology, Research Center Borstel, Airway Research
Center North (ARCN), Member of the German Center for Lung Research (DZL), Borstel
, Germany;
2
Department of Dermatology and Allergology, University of Lübeck , Germany
Background: Peanut allergy is one of the most severe class I food allergies with an
increasing prevalence over the past decades. The tight association between serious
allergic symptoms and the presence of a class of lipophilic proteins, called oleosins,
has been clearly shown for several oil-rich plants, but not for peanut. Since allergy
diagnostic testing is based on aqueous extracts, potential allergenic proteins of
lipophilic nature are usually underrepresented or even absent. To close the existing
detection gap in the established peanut allergy diagnostics, our study focused on
the isolation, molecular characterization and assessment of the allergenicity of peanut
oleosins.
Methods: A comprehensive method for the isolation of oleosins was developed. This
method comprised a step by step removal of seed storage proteins from peanut oleosins.
Oleosin separation was carried out by preparative electrophoresis. Subsequent N-terminal
sequencing, peptide mass fingerprinting and homology search were used for the identification
of oleosins. Evaluation of the IgE-binding capacity was conducted by immunoblot analysis
with sera of peanut-allergic individuals.
Results: Highly purified oleosins were isolated from the complex lipophilic matrix
of peanut. Further separation of the different oleosins was realized by a single run
on an electrophoresis cell. All known peanut oleosins were identified by mass spectrometry
and N-terminal sequencing, including the allergens Ara h 10, Ara h 11, the presumed
allergen oleosin 3 and additional oleosins variants. Western blotting illustrated
the allergenicity of these immunologically distinct oleosins.
Conclusion: Our method provides a novel strategy to isolate all known peanut oleosins
simultaneously. Furthermore, there is some evidence that oleosins are relevant allergens
linked to a severe peanut allergy. Hence, oleosins are introduced as important candidates
for the component-resolved diagnostic.
V38
Development of a sensitive and specific sandwich-ELISA for the detection of the peanut
marker allergen Ara h 2 in human breast milk
A. Scharf1, F. Schocker1, U. Jappe1, 2
1
Division of Clinical and Molecular Allergology, Research Center Borstel, Airway Research
Center North (ARCN), Member of the German Center for Lung Research (DZL), Borstel,
Germany;
2
Department of Dermatology and Allergology, University of Lübeck, Germany
Background: Peanut allergy is a severe food allergy which already occurs in early
childhood, frequently on first known oral exposure to peanuts. Therefore, the transfer
of allergens via breast milk is discussed as a possible sensitization route. In a
Canadian study, peanut proteins have been identified in lactating women, but without
further specification. In addition, another study showed the transfer of Ara h 6 into
breast milk in 2 subjects. With regard to a possible sensitization via breast milk,
our aim was to establish a sandwich-ELISA for the quantification of the peanut marker
allergen Ara h 2.
Methods: A German cohort of 40 lactating women without peanut allergy was established.
After a 24-hour legume-free diet, Ara h 2 levels were assessed in human breast milk
before (as basal sample) and at different time points between 1 to 12 hours after
ingestion of 100 g roasted peanuts. In order to develop a sandwich-ELISA directed
against Ara h 2 for the detection in human breast milk, antibody-matching, cross-reactivity
analysis and buffer evaluation were performed using anti-Ara h 2 antibodies of different
origins and different Ara h 2 epitope-specificity.
Results: The optimized sandwich-ELISA for Ara h 2 detection in breast milk has a detection
limit of 2.5 ng/mL. Additionally, no cross-reactivity against Ara h 6 and other legume
extracts was found. The intra-assay coefficient of variation (CV) was 4.1%, and the
inter-assay CV was 12.6%. Using this ELISA, Ara h 2 was detected in breast milk samples
from 16/40 subjects (range: 2.6 to 194 ng/mL).
Conclusion: By means of a sandwich-ELISA, we established a sensitive and specific
diagnostic tool for the determination of Ara h 2 in human breast milk. Thus, we are
able to show the transfer of the peanut marker allergen into breast milk of 40% of
the lactating women. These results are important with respect to an occult sensitization
via breast milk and the implementation of prevention strategies for children at risk.
V39
The conformational IgE epitope profile of soybean allergen Gly m 4
F. Husslik1, J. Nürnberg1, C. Seutter von Loetzen2, B. Ballmer-Weber3, J. Kleine-Tebbe4,
R. Treudler5, S. Randow1, E. Völker1, L. Vogel1, A. Reuter1, . Rösch2, S. Vieths1,
T. Holzhauser1, D. Schiller1
1
Paul-Ehrlich-Institut, Langen, Deutschland;
2
Universität Bayreuth, Deutschland;
3
Universitätsklinik Zürich, Schweiz;
4
Allergie Zentrum Westend, Berlin, Deutschland;
5
Universität Leipzig, Deutschland
Background: Birch pollen-related soy allergy is mediated by soy allergen Gly m 4 and
causes mild to severe, i.e. anaphylaxis, clinical symptoms. Due to structural homology
of Gly m 4 to the major birch pollen allergen Bet v 1 clinical cross-reactivity of
Bet v 1-specific IgE is observed. Clinically relevant IgE binding sites of Gly m 4
are not known.
Objective: To identify the IgE sensitization pattern of Gly m 4 in subjects with birch
pollen-related soy allergy with an allergen-type model protein.
Methods: Sera from 47 birch pollen-allergic patients with (27 subjects) and without
(20 subjects) clinical reactivity to soy as determined by oral provocation tests were
studied. Specific IgE against Bet v 1 and Gly m 4 was determined by ImmunoCAP. A library
of 46 non-allergenic Gly m 4-type model proteins harboring putative individual binding
sites for serum IgE was generated and tested for IgE binding in immunoassays. Variants
of model proteins combining individual and multiple IgE binding sites were purified
and tested for competing with Gly m 4-specific IgE. Secondary and tertiary structures
of model proteins were assessed by CD and NMR spectroscopy.
Results: Gly m 4- and Bet v 1-specific serum IgE levels ranged from 0 to >100 kUA/L.
Purified model proteins exhibited Gly m 4-like conformation. 39% (18/46) of model
proteins carrying individual IgE epitopes bound serum IgE of more than 50% of the
study population. IgE binding to model proteins with individual and multiple substitutions
could be inhibited with rGly m 4 and vice versa in a dose-dependent manner.
Conclusion: Levels of Gly m 4-specific IgE of sera of birch-soy allergic patients
do not correlate with clinical reactivity to soy. 36 Gly m 4-specific amino acids
that comprise a minimum number of 6 epitopes were identified and can be correlated
to individual clinical symptoms to judge potential clinical relevance of IgE binding
sites.
V40
Dietary Wheat Alpha-Amylase-Trypsin Inhibitors (ATIs) Worsen Intestinal Inflammation
in Mice
G. Pickert1, R. Heck1, A. Weigert2, D. Schuppan1
1
Institute of Translational Immunology, Mainz, Germany;
2
Institute of Biochemistry I, Frankfurt, Germany
Background and Aims: The inflammatory bowel diseases (IBD) Crohn‘s disease and ulcerative
colitis (UC) are characterized by a chronic self-destructive inflammation of the gastrointestinal
tract. We have recently identified alpha-amylase-trypsin inhibitors (ATIs), non-gluten
components of wheat, as potent activators of innate immunity by engaging the toll
like receptor 4 (TLR4)-MD2-CD14 complex in monocytes, macrophages and dendritic cells
(Junker Y et al, J Exp Med 2012). ATIs that are present even in „pure“ gluten preparations
are implicated also as promoters in the pathogenesis of celiac disease and possibly
other autoimmune / inflammatory diseases. Therefore, we studied the effect of dietary
Gluten/ATIs on intestinal inflammation.
Methods and Results: C57BL/6 mice were set on a gluten-free diet (GFD) or (a usually
gluten containing) standard-diet (STD) and subject to dextran sodium sulphate (DSS)-
induced colitis (2.5% DSS in drinking water for 7-14 days). The GFD diet strongly
reduced colonic inflammation compared to the STD. GFD fed mice maintained normal body
weight, showed attenuated inflammation with reduced numbers of infiltrating inflammatory
cells in the colonic mucosa and lacked epithelial erosions. Transcript levels of pro-inflammatory
cytokines such as IL-1β and IL-6 in the intestine were significantly down-regulated
in colitic C57BL/6 mice kept on a gluten- free diet compared to mice fed the STD.
Furthermore the mouse model of T cell transfers DSS- induced colitis in RAG1-/- mice
indicated a T cell mediated response in dietary gluten was an important trigger of
T cell mediated inflammation.. FACS analyses revealed that dietary (ATI-containing)
gluten altered the balance of pro-inflammatory (IL-17, IFN-g) and anti-inflammatory
(IL-10) cytokines in T cells of lymphoid compartments (spleen, mesenteric lymph nodes)
and in the mucosa towards a pro-inflammatory state. DSS- induced severe colitis in
mice fed the STD was accompanied by a shift towards a proinflammatory microbiota.
V41
Apical exposure to dietary non-digestible oligosaccharides and bacterial CpG DNA suppresses
Th2 type chemokine release by activated intestinal epithelial cells
S. Overbeek1, M. Boks2, D. Dittlein3, W. de Jager4, J. Garssen1, 5, L. Willemsen1
1
Utrecht University, the Netherlands;
2
VUMC Amsterdam, the Netherlands;
3
UNIKA-T, Institut fuer Umweltmedizin, Technische Universität München, Augsburg, Deutschland;
4
UMC Utrecht, the Netherlands;
5
Nutricia Research, the Netherlands
Background: Dietary short chain galacto- and long chain fructo-oligosaccharides (scGOS/lcFOS)
and TLR9 ligand CpG DNA affect intestinal epithelial cell (IEC) function. Epithelial
derived IL-1α is known to contribute to allergic sensitization in the lung.
Aim: To study the effect of IL-1α on Th2 polarizing chemokine release by IEC and the
modulatory effect of scGOS/lcFOS and CpG DNA in presence or absence of monocyte derived
dendritic cells (moDC).
Methods: HT-29 cells (IEC) cultured in transwells were pre-incubated basolaterally
with IL-1α± IFNγ/TNFα and apically with scGOS/lcFOS ± CpG DNA for 6 hours, washed
and basolaterally exposed to immature moDC or medium while apically exposed to scGOS/lcFOS
± CpG for 24-48 hours. Th2 driving IL-25, CCL2, CCL22 and regulatory galectin-9 and
TGF were measured in basolateral supernatants. After 48h of co-culture, moDC were
added to allogenic naïve T-cells for 6 days (MLR) and cytokines were measured.
Results: Combined IFNγ/TNFα activation induced the release of CCL2 and CCL22 by IEC,
which was further enhanced by IL-1α. IFNγ/TNFα ± IL-1α activation also increased galectin-9
and TGF (24h). Exposure to scGOS/lcFOS ± CpG DNA reduced CCL2 and CCL22, while galectin-9
and TGF remained high. In the 48h supernatants of IEC/moDC co-cultures, scGOS/lcFOS
enhanced galectin-9 in presence or absence of CpG DNA. scGOS/lcFOS plus CpG DNA reduced
IL-25 in co-cultures pre-exposed to IFNγ/TNFβ/IL-1α while increasing IFNγ concentrations
in the MLR.
Conclusion: IL-1α enhances Th2 polarizing chemokine release by IFNγ/TNFα activated
IEC. Combined exposure to dietary scGOS/lcFOS plus CpG DNA suppresses this response
skewing away from the allergic phenotype.
This study was performed within the framework of Dutch Top Institute Pharma (T1.501).
V42
Administration of recombinant GARP inhibits allergen-induced colitis in a humanized
mouse model of allergy
I. Bellinghausen1, B. Weigmann2, S. Reissig3, A. Waisman3, J. Saloga1
1
Department of Dermatology, University Medical Center, Johannes Gutenberg-University,
Mainz, Germany;
2
Department of Internal Medicine I, University Hospital Erlangen, University Erlangen-Nürnberg,
Germany;
3
Institute for Molecular Medicine, University Medical Center, Johannes Gutenberg-University,
Mainz, Germany
Previously, we could demonstrate that the inhibition of allergen-induced IgE-dependent
gut inflammation in PBMC-engrafted immunodeficient mice by regulatory T cells (Treg)
was dependent on the Treg activation marker glycoprotein A repetitions predominant
(GARP). Besides its role on the regulatory function of Treg, GARP has been shown to
possess anti-inflammatory properties by enhancing Treg activity in vitro and in vivo.
The aim of this study was to investigate whether GARP might be protective in our humanized
mouse model of allergy, too. Therefore, NOD-scid-γc-/- mice were injected intraperitoneally
with human PBMC from allergic donors together with the respective allergen in the
presence or absence of recombinant GARP or, for comparison, activated Treg of the
same donor. After an additional allergen boost one week later, mice were challenged
with the allergen rectally on day 21 and gut inflammation was monitored by a high
resolution video mini-endoscopic system evaluating translucency, granularity, fibrin
production, vascularity, and stool. Administration of GARP reduced the number of migrated
CD45+ human cells in mice. Furthermore, an increased amount of FoxP3+ cells could
be observed. Consequently, total and allergen-specific human IgE production in mouse
sera was almost as strongly inhibited in GARP-treated mice as shown for co-injection
of activated Treg leading to a similar prevention of allergen-induced gut inflammation
after rectal allergen challenge. These results demonstrate that activation of Treg
by GARP may be an additional tool for therapeutic intervention of allergic diseases
of the intestine.
Posters
P01
Evaluation of pet ownership and allergen exposure among school children in 3 Luxembourgish
secondary schools
M. Mersch1, S. Kler2, K. Swiontek2, F. Hentges2, M. Ollert2, C. Hilger2
1Lycée Classique Diekirch, Germany; 2CRP-Santé, Luxemburg, Luxemburg
Background: Exposure to cat and dog allergens is considered as important risk factor
for development of asthma and rhinitis. The prevalence of small furry animals seems
to be increasing in households of industrialized countries, but epidemiological data
on small animals and exposure in schools are still lacking.
Methods: Questionnaires were distributed to 1761 pupils in three secondary schools
in Luxembourg in order to record the prevalence of pets in families with children
of school age. Electrostatic dust collectors were exposed for two weeks in representative
classrooms with low to high pet prevalence. Additional dust collectors were exposed
at 40 homes of children with and without pets. Dust samples were extracted and the
marker allergens Can f 1, Fel d 1, Cav p 2 and Ory c 3 were quantified.
Results: Total pet prevalence was 66%, 36% kept a dog, 31% a cat, 14% a rabbit, 4%
a guinea-pig and 3% a hamster. 11% had at least once a week contact with horses and
8% were living on a farm. Can f 1 and Fel d 1 levels were significantly different
between the three schools. Levels between classes with presence of many pet owners
and few pet owners were variable and differences were not significant. No guinea-pig
allergens could be detected, but low levels of rabbit allergen were present in some
classrooms. Can f 1 levels measured in schools (median 55.3 ng/m2, range 0-533) reached
values similar to those measured in homes of dog owners (median 253.8 ng/m2, range
0-2201). Fel d 1 was measured at comparable levels as Can f 1 in schools (median 69.7
ng/m2, range 0-457) and in homes of cat owners (median 117.3 ng/m2, range 0-2448).
Conclusion: The prevalence of pets in families of Luxembourgish school children is
much higher than the European average. Allergen levels varied significantly between
the 3 schools analysed. Levels of Can f 1 and Fel d 1 measured in some classes are
comparable to values obtained in homes of pet owners and constitute a risk factor
for allergic children.
P02
Microbial colonization of pollen and their contribution to allergy
A. Bauer1, U. Frank1, S. Gilles2, D. Ernst1, C. Traidl-Hoffmann2, M. Schmid1, A. Hartmann1
1
Helmholtz Forschungszentrum München, Oberschleißheim, München, Deutschland;
2
Center for Allergy and Environment (ZAUM), München, Germany
All over the world the occurrence of allergic diseases increased during the last decades.
One major causative factor are airborne pollen grains of amenophilic plants, e. g.
diverse grasses and trees. The allergenic potential of pollen depends on the amount
of produced allergenic proteins (e.g. PALMs), which also seemed to be involved in
the plant’s defense mechanisms. Soil or air pollution could affect the plant’s capability
to defense itself against contamination with microbes. Up to now little is known about
the composition of microbial communities colonizing allergenic plants (or their reproductive
organs like pollen grains) and in what extent this contamination might influence the
plant’s production of allergenic proteins. In this study we grew pure cultures of
cultivable microorganisms on different media isolated from pollen of timothy grass
and birch. For identification we used comparative 16S-rDNA and ITS1-2 sequence analysis,
respectively. We also applied T-RFLP fingerprint techniques, a culture independent
method based on the amplification of the 16S-rRNA gen, to determine the composition
of the microbial population on the pollen. Furthermore we did statistical correlation
analysis of microbial contamination, several environmental parameters and the content
of immune modulatory PALMs from pollen sampled on different locations as well as principal
components analysis, analysis of similarity and cluster analysis.
So far affiliated microbial isolates associated with pollen belong to Bacillus sp.
and Pseudomonas sp., but also to phytopathogenic genera like Pantoea sp. or the phytotoxic
fungy Fusarium sp. After proving the reproducibility of the analytical microbiom-data,
evidences of distinct colonizing patterns could be shown on different pollen species.
The data were compared due to cultivable microbes from these pollens, the amount of
produced immune-modulatory compounds (e.g. PGE2) as well as concerning the influence
of environmental parameters.
P03
Airway surface dehydration impairs pulmonary allergen clearance
M. Hagner1, S. Schmidt1, E. Maier1, S. Christochowitz1, M. Lampe2, M. Mall1, B. Fritzsching1
1
Department of Translational Pulmonology, Translational Lung Research Center (TLRC),
Member of the German Center of Lung Research (DZL), University of Heidelberg, Germany;
2
European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
Introduction: Efficient clearance of inhaled allergens from the lungs of patients
with allergic asthma is important to avoid prolonged allergen exposure and asthma
exacerbation. We hypothesized that impaired mucociliary clearance constitutes a risk
factor for inefficient intrapulmonary allergen clearance. Thus, we analyzed allergen
clearance mechanisms in wild type (WT) mice and in mice with airway-specific overexpression
of the sodium channel ENaC (βENaC-Tg), which suffer from airway surface dehydration,
impaired mucociliary clearance and chronic airway inflammation [Mall et al., Nat Med.,
2004].
Methods: Mucociliary clearance was determined by intratracheal application of 1 µm
fluorescent beads and video-microscopic analysis of in vivo bead elimination. Following
intrapulmonary application of fluorescently labeled Aspergillus fumigatus extract
(Af), total allergen clearance was analyzed by measurement of residual fluorescence
in lung homogenates after designated time points. Bronchoalveolar lavage (BAL) from
WT and βENaC-Tg mice was analyzed by flow cytometry to identify immune cell populations
with Af uptake.
Results: Mucociliary clearance and total lung allergen clearance were significantly
reduced in βENaC Tg-mice compared to WT mice. Antigen-presenting cells including alveolar
macrophages (AM) and conventional dendritic cells (cDCs) were identified as cell types
with strongest Af uptake among immune airway cells. In addition to decreased total
allergen clearance, βENaC-Tg mice showed reduced allergen uptake by AM when compared
to WT mice. However, the level of allergen presenting airway cDCs was significantly
elevated in βENaC-Tg mice.
Conclusion: We conclude that airway surface dehydration impairs pulmonary allergen
clearance. Hence, we suggest that inefficient allergen clearance might contribute
to increased allergen presentation by cDCs which could constitute a risk factor for
allergic sensitization during chronic airway inflammation.
P04
Airway dehydration increases pulmonary IL-13 expression in vivo
S. Christochowitz1, C. van Bodegom1, S. Schmidt1, E. Maier1, M. Hagner1, J. Fellenberg2,
M. Mall1, B. Fritzsching1
1
Department of Translational Pulmonology, Translational Lung Research Center (TLRC),
Member of the German Center for Lung Research (DZL), University of Heidelberg, Germany;
2
Department of Orthopedics and Traumatology, University Hospital Heidelberg, Germany
Rationale: We have previously demonstrated that mice with airway specific overexpression
of the epithelial Na+ channel (βENaC-Tg) exhibit airway surface dehydration and eosinophilic
airway inflammation in juvenile mice (Mall MA, 2008). We hypothesized that airway
surface dehydration may increase the susceptibility for allergic airway inflammation
and treatment with allergen could induce IL-13 expression in vivo. Here, we evaluated
cellular sources of IL-13 expression in response to allergen treatment in wild-type
and βENaC-Tg mice.
Methods: Juvenile wild-type and βENaC-Tg mice were challenged intratracheally with
Aspergillus fumigatus (Af) extract. In vitro restimulated whole lung-derived leukocytes
were analyzed for IL-13 expression by multicolor flow cytometry. Laser microdissection
(LMD) of the airway epithelium and subsequent nested qPCR were performed for quantification
of airway-specific mRNA expression of IL-13, IL-33, IL-25, TSLP and periostin. IL-13
expression was confirmed by immunohistochemistry with IL13-/- mice-derived lung tissue
as negative control.
Results: Intrapulmonary exposure of Af significantly increased airway eosinophils
and pulmonary IL-13 in βENaC-Tg mice. We observed elevated numbers of pulmonary IL-13+-cells
among macrophages, Th2-, B- and ILC2-cells in βENaC-Tg mice by 11-color flow cytometry,
which was further increased in response to Af treatment in Th2- and ILC2-cell populations.
LMD revealed airway epithelial cell-specific expression of IL-13 and IL-33 but not
TSLP and IL-25 in βENaC-Tg mice. Immunostaining confirmed epithelium-mediated IL-13
protein expression, which was enhanced after Af challenge in βENaC-Tg mice.
Conclusion: We demonstrate that airway surface dehydration is a risk factor for allergic
airway inflammation including increased frequencies of IL-13+-cells in response to
allergen. Expression of IL-13 is not limited to Th2 cells, but also ILC2 cells and
airway epithelium provide substantial amounts of IL-13 in vivo.
P05
Acute Influenza Virus Infection protects of allergic airway inflammation in the OVA-mouse
model
C. Hudemann1, C. Skevaki1, M. Matrosovich2, H. Renz1
1
Institute of Laboratory Medicine and Pathobiochemistry, Philipps Universität, Marburg,
Germany;
2
Institut of Virology, Philipps Universität, Marburg, Germany
Airway viral infections heavily affect allergic asthma and other chronic airway inflammatory
diseases. Epidemiological and clinical data display contradictory effects in terms
of asthma prevention and asthma exacerbation in already diseased patients. The molecular
basis of these phenotype-modifying virus-host interactions, however, is still largely
unknown. This leads us to the hypothesis that the impact of viral infections on the
development of chronic inflammation depends on (i) virus origin and frequency of viral
infection as well as (ii) on host immune status and localization of infection.
Here, we describe a novel prevention model of influenza airway infection followed
by succeeding OVA-sensitization and -challenge in Balb/c mice. A single infection
using the pandemic Hamburg/09 H1N1 causes a quick influx and activation of CD4 and
CD8 T-cell populations peaking at day 8-12 combined with a pronounced TNF-α, IFN-γ
and IL-6 secretion pattern. Virus-specific tetramer-pos. cytotoxic T- and effector
memory cells peak in the lung at day 12 followed by a migration into spleen. Even
60 days post infection, tetramer-pos cytotoxic T-cells were detected in both lung
and spleen. A subsequent OVA-sensitization starting from 12 or 33days post infection
followed by challenge displayed a decreased severity of a wide range of allergic phenotypic
parameters (e.g. eosinophilia p<0.05, goblet cell hyperplasia p<0.05, IL-5 p<0.05)
compared to only OVA-treated group. CD8 memory cell subpopulations displayed a characteristic
redistribution pattern, and further in-vitro analysis points towards a protective
role based on cross-reactive sequence recognition leading to a virus induced dampening
of a subsequent allergic phenotype. Delineation of the underlying molecular and cellular
rearrangements will lead to a better understanding of the regulations of chronic inflammation
and should identify novel targets for virus induced protection and exacerbation.
P06
Evaluation of individual sensitization patterns to shrimp allergens in patients with
seafood allergy using ImmunoCAP ISAC microarray
W. Hemmer, F. Wantke, S. Wöhrl
Floridsdorf Allergy Centre, Vienna, Austria
Background: Seafood is an important cause of anaphylaxis worldwide and considered
to be closely associated with house dust mite allergy due to cross-reactivity between
the tropomyosins of mites, shrimps and molluscs. We assessed the prevalence of sensitization
to different shrimp allergens in seafood-allergic subjects and explored the relationship
with house dust mite allergy.
Methods: Sera from 108 patients (43m/65f, mean age 37.7±15.7 yrs) with a history of
shrimp allergy and a positive routine test result to seafood (skin prick test and/or
sIgE) were retrospectively analyzed by ImmunoCAP ISAC® for IgE antibodies against
tropomyosin (nPen m 1, rDer p 10, nBla g 7), shrimp arginine kinase (nPen m 2), shrimp
sarcoplasmatic calcium-binding protein (nPen m 4), as well as the major dust mite
allergens nDer p /f 1 and rDer p/f 2.
Results: 67/108 sera (62%) reacted with at least one shrimp allergen in the microarray,
whereas 38% were negative despite a positive CAP result to crude shrimp extracts.
Sensitization to Pen m 1 was most prevalent (42.6%) followed by Pen m 4 (25.0%) and
Pen m 2 (13.9%). 73% of the patients were monosensitized to only one molecule, mainly
to Pen m 1 (65%) or Pen m 4 (63%) while sensitization to Pen m 2 was rarely monovalent
(13%). Only 23/67 sera (34.3%) were positive to the major dust mite allergens Der
p/f 1 or Der p/f2. Correlating sensitization profiles with symptom severity after
seafood ingestion revealed that tropomyosin sensitization is regularly associated
with systemic reactions while symptoms are often milder in case of sensitization to
Pen m 2 and 4. Reactions were most severe in those with negative ISAC.
Conclusions: Although tropomyosin can be confirmed as an important seafood allergen,
it accounts for only 43% of cases. 38% of seafood-allergic subjects are sensitized
to unknown allergens other that Pen m 1, 2 or 4. IgE to Der p/f 1/2 is inconsistently
found questioning a close causal relationship between house dust mite and seafood
allergy.
P07
Sublingual immunotherapy with house dust mite extracts prevents the development of
allergic asthma in a mouse model
S. Brand, C. Rask, J. Brimnes, S. Urioste, K. Lund
ALK, Global Research, Immunology, Hørsholm, Dänemark
Rationale: The persistent increase in the prevalence of asthma and allergic diseases
highlights the need for effective disease management. The effectiveness of specific
immunotherapy for preventing the progression of rhinitis to allergic asthma in children
has been established, but to date there are no published clinical data on specific
immunotherapy as a strategy for primary prevention of allergic diseases. In this study,
we use a mouse model to address whether sublingual administration of allergen is able
to prevent the induction of allergic asthma.
Methods: A mouse model, in which mice develop allergen-specific IgE, local allergic
inflammation in the respiratory tract and increased airway hyperresponsiveness after
sensitization and airway challenge with house dust mite extract, has been developed.
House dust mite extract was sublingually administered to naïve mice for 10 days before
sensitization and subsequent challenge. Airway hyperresponsiveness was determined
after intra-nasal challenge on three consecutive days. Mice were sacrificed one day
later and eosinophil attraction to broncho-alveolar lavage, systemic and local proliferative
and Th2 cytokine responses as well as allergen-specific IgE in serum were analyzed.
Results: Compared to the buffer-treated control group mice treated sublingually with
allergen extract were refractory to the development of airway hyperresponsiveness,
eosinophil attraction to broncho-alveolar lavage (BAL), allergen-specific IgE in serum
and systemic proliferative responses following allergen challenge.
Conclusions: We could show that prophylactic sublingual treatment with allergen extract
prevents the development of house dust mite induced allergic asthma in a mouse model.
Clinical studies are required in order to determine whether this concept also holds
true for humans.